Transfection of primary chondrocytes using chitosan-pEGFP nanoparticles

Journal of Controlled Release

Volumn 112, Issue 2, 2006, Pages 223-228

  Zhao, Xia ^a   Yu, Shi Bing ^b   Wu, Feng Lan ^a   Mao, Ze Bin ^c   Yu, Chang Long ^b  

^a PEKING UNIVERSITY   (China)

^b PEKING UNIVERSITY THIRD HOSPITAL   (China)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Chitosan; Chondrocytes; Nanoparticles; Non viral gene delivery

Indexed keywords

CATIONIC POLYMERIZATION; DISEASES; GENE TRANSFER; PARTICLE SIZE ANALYSIS;

CHITOSAN; CHONDROCYTES; NANOPARTICLES; NON-VIRAL GENE DELIVERY;

NANOSTRUCTURED MATERIALS;

CATION; CHITOSAN; DNA; EPIDERMAL GROWTH FACTOR; NANOPARTICLE; POLYMER;

ANIMAL CELL; ARTHROPATHY; ARTICLE; CARTILAGE CELL; CELL COUNT; COACERVATION; CONTROLLED STUDY; DNA DRUG COMPLEX; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; FLUORESCENCE ACTIVATED CELL SORTING; GENE TARGETING; GENE TRANSFER; GENE VECTOR; GENETIC TRANSFECTION; MOLECULAR WEIGHT; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; PH; PLASMID; PRIORITY JOURNAL; RABBIT; ZETA POTENTIAL;

ANIMALS; CHITOSAN; CHONDROCYTES; DNA; GREEN FLUORESCENT PROTEINS; KNEE JOINT; MOLECULAR WEIGHT; NANOSTRUCTURES; RABBITS; TRANSFECTION;

EID: 33646133667     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2006.01.016     Document Type: Article

References (35)

1. Alleyne K.R., and Galloway M.T. Management of osteochondral injuries of the knee. Clin. Sports Med. 20 2 (2001) 343-364
2. Browne J.E., and Branch T.P. Surgical alternatives for treatment of articular cartilage lesions. J. Am. Acad. Orthop. Surg. 8 3 (2000) 180-189
3. Kish G., Modis L., and Hangody L. Osteochondral mosaicplasty for the treatment of focal chondral and osteochondral lesions of the knee and talus in the athlete: rationale, indications, techniques, and results. Clin. Sports Med. 18 1 (1999) 45-66
4. Martinek V., Fu F.H., Lee C.W., and Huard J. Treatment of osteochondral injuries: genetic engineering. Clin. Sports Med. 20 2 (2001) 403-416
5. Frenkel S.R., and Di Cesare P.E. Degradation and repair of articular cartilage. Front. Biosci. 4 (1999) D671-D685
6. Malemud C.J., and Goldberg V.M. Future directions for research and treatment of osteoarthritis. Front. Biosci. 4 (1999) D762-D771
7. Vangsness Jr. C.T. Overview of treatment options for arthritis in the active patient. Clin. Sports Med. 18 1 (1999) 1-11
8. Ulrich-Vinther M., Maloney M.D., Schwarz E.M., et al. Articular cartilage biology and regeneration. J. Am. Acad. Orthop. Surg. 11 6 (2003) 421-430
9. Evans C.H., Ghivizzani S.C., Kang R., et al. Gene therapy for rheumatic diseases. Arthritis Rheum. 42 1 (1999) 1-16
10. Pfeifer A., and Verma I.M. Gene therapy: promises and problems. Annu. Rev. Genomics Hum. Genet. 2 (2001) 177-211
11. Oligino T.J., Yao Q., Ghivizzani S.C., and Robbins P. Vector systems for gene transfer to joints. Clin. Orthop. Relat. Res. 379S (2000) S17-S30
12. Robbins P.D., and Ghivizzani S.C. Viral vectors for gene therapy. Pharmacol. Ther. 80 1 (1998) 35-47
13. Verma I.M., and Somia N. Gene therapy-promises problems and prospects. Nature 389 6648 (1997) 239-242
14. Abdallah B., Sachs L., and Demeneix B.A. Non-viral gene transfer: applications in developmental biology and gene therapy. Biol. Cell 85 1 (1995) 1-7
15. Kim H.J., Greenleaf J.F., and Kinnick R.R. Ultrasound-mediated transfection of mammalian cells. Hum. Gene Ther. 7 11 (1996) 1339-1346
16. Madry H., and Trippel S.B. Efficient lipid-mediated gene transfer to articular chondrocytes. Gene Ther. 7 4 (2000) 286-291
17. Madry H., Padera B., Seidel J., et al. Gene transfer of a human insulin-like growth factor I cDNA enhances tissue engineering of cartilage. Hum. Gene Ther. 13 13 (2002) 1621-1630
18. Dinser R., Kreppel F., Zaucke F., et al. Comparison of long-term transgene expression after non-viral and adenoviral gene transfer into primary articular chondrocytes. Histochem. Cell Biol. 116 1 (2001) 69-77
19. Stove J., Fiedler J., Huch K., et al. Lipofection of rabbit chondrocytes and long lasting expression of a lacZ reporter system in alginate beads. Osteoarthr. Cartil. 10 3 (2002) 212-217
20. Madry H., Cucchiarini M., Stein U., et al. Sustained transgene expression in cartilage defects in vivo after transplantation of articular chondrocytes modified by lipid-mediated gene transfer in a gel suspension delivery system. J. Gene Med. 5 6 (2003) 502-509
21. Fernandes J., Tardif G., Martel-Pelletier J., et al. In vivo transfer of interleukin-1 receptor antagonist gene in osteoarthritic rabbit knee joints: prevention of osteoarthritis progression. Am. J. Pathol. 154 4 (1999) 1159-1169
22. Mao H.Q., Roy K., Troung-Le V.L., et al. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J. Control. Release 70 3 (2001) 399-421
23. Sato T., Ishii T., and Okahata Y. In vitro gene delivery mediated by chitosan. Effect of pH, serum, and molecular mass of chitosan on the transfection efficiency. Biomaterials 22 15 (2001) 2075-2080
24. Richardson S.C., Kolbe H.V., and Duncan R. Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA. Int. J. Pharm. 178 2 (1999) 231-243
25. MacLaughlin F.C., Mumper R.J., Wang J., et al. Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. J. Control. Release 56 1-3 (1998) 259-272
26. Ishii T., Okahata Y., and Sato T. Mechanism of cell transfection with plasmid/chitosan complexes. Biochim. Biophys. Acta 1514 1 (2001) 51-64
27. Corsi K., Chellat F., Yahia L., and Fernandes J.C. Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles. Biomaterials 24 7 (2003) 1255-1264
28. Koping-Hoggard M., Tubulekas I., Guan H., et al. Chitosan as a nonviral gene delivery system. Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo. Gene Ther. 8 14 (2001) 1108-1121
29. Li X.W., Lee D.K., Chan A.S., and Alpar H.O. Sustained expression in mammalian cells with DNA complexed with chitosan nanoparticles. Biochim. Biophys. Acta 1630 1 (2003) 7-18
30. Erbacher P., Zou S., Bettinger T., et al. Chitosan-based vector/DNA complexes for gene delivery: biophysical characteristics and transfection ability. Pharm. Res. 15 9 (1998) 1332-1339
31. Suh J.K., and Matthew H.W. Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: a review. Biomaterials 21 24 (2000) 2589-2598
32. Pedroso de Lima M.C., Simoes S., Pires P., et al. Cationic lipid-DNA complexes in gene delivery: from biophysics to biological applications. Adv. Drug Deliv. Rev. 47 (2001) 277-294
33. Thomas M., and Klibanov A.M. Non-viral gene therapy: polycation-mediated DNA delivery. Appl. Microbiol. Biotechnol. 62 (2003) 27-34
34. Venkatesh S., and Smith T.J. Chitosan-membrane interactions and their probable role in chitosan-mediated transfection. Biotechnol. Appl. Biochem. 27 (1998) 265-267 (Part 3)
35. Romøren K., Pedersen S., et al. The influence of formulation variables on in vitro transfection efficiency and physicochemical properties of chitosan-based polyplexes. Int. J. Pharm. 261 (2003) 115-127